The results indicated that the hepatic FGFR4/β-klotho signaling was significantly upregulated in the FGF21KO-HFMCD mice, implying that severity of NASH might associate to the aberrant FGFR4/β-klotho signaling. Here, KLB is linked to metabolic dysfunction-associated steatohepatitis.